Prehospital exenatide in hyperglycemic stroke—A randomized trial
- 13 September 2019
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 140 (6) , 443-448
Abstract
Objectives Hyperglycemia is a predictor for poor stroke outcome. Hyperglycemic stroke patients treated with thrombolysis have an increased risk of intracranial hemorrhage. Insulin is the gold standard for treating hyperglycemia but comes with a risk of hypoglycemia. Glucagon like peptide‐1 receptor agonists (GLP‐1RA) are drugs used in type 2 diabetes that have a low risk of hypoglycemia and have been shown to exert neuroprotective effects. The primary objective was to determine whether prehospital administration of the GLP‐1RA exenatide could lower plasma glucose in stroke patients. Secondary objective was to study tolerability and safety. Materials & Methods Randomized controlled trial comparing exenatide administrated prehospitally with a control group receiving standard care for hyperglycemia. Patients with Face Arm Speech Test ≥1 and glucose ≥8 mmol/L were randomized. Glucose was monitored for 24 hours. All adverse events were recorded. Results 19 patients were randomized, 8 received exenatide. An interim recruitment failure analysis with subsequent changes of the protocol was made. The study was stopped prematurely due to slow inclusion. No difference was observed in the main outcome of plasma glucose at 4h; control vs. exenatide [mean, SD] (7.0 ± 1.9 vs. 7.6 ± 1.6; p=0.56). No major adverse events were reported. Conclusions We found no evidence that prehospital exenatide had effect on hyperglycemia. However, it was given without adverse events in this study with limited sample size that was prematurely stopped due to slow inclusion.Keywords
Funding Information
- European Foundation for the Study of Diabetes
- STROKE-Riksförbundet
This publication has 32 references indexed in Scilit:
- Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature reviewJournal of Diabetes Investigation, 2018
- Global Burden of StrokeCirculation Research, 2017
- Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet Global Health, 2013
- Intensive Versus Subcutaneous Insulin in Patients With Hyperacute StrokeStroke, 2012
- Hyperglycemia in acute ischemic stroke: pathophysiology and clinical managementNature Reviews Neurology, 2010
- Favorable Trends in the Incidence and Outcome in Stroke in Nondiabetic and Diabetic SubjectsStroke, 2008
- Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)The Lancet Neurology, 2007
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001
- Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up studyBMJ, 1997
- Diabetes and cardiovascular risk factors: the Framingham study.Circulation, 1979